A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Yale University
Immatics US, Inc.
Genmab
M.D. Anderson Cancer Center
Alpha Tau Medical LTD.
Prescient Therapeutics, Ltd.
Bayer
Daiichi Sankyo
Chengdu Zenitar Biomedical Technology Co., Ltd
ModernaTX, Inc.
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
CytomX Therapeutics
OncoNano Medicine, Inc.
Fondazione Italiana Linfomi - ETS
Alpha Tau Medical LTD.
Novelwise Pharmaceutical Corporation
Treeline Biosciences, Inc.
Lyell Immunopharma, Inc.
City of Hope Medical Center
Biogen
Vejle Hospital
City of Hope Medical Center
Maastricht University Medical Center
Yale University
University of Aarhus
Vastra Gotaland Region
Stanford University
University College, London
Melanoma and Skin Cancer Trials Limited
BeiGene
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Kyowa Kirin Co., Ltd.
Herlev and Gentofte Hospital
National Cancer Institute (NCI)
Zai Lab (Hong Kong), Ltd.
Maastricht University Medical Center
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
University of Kansas Medical Center
Provectus Pharmaceuticals
Jonsson Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center